Canine COVID-19 Detection
NCT04509713 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 16250
Last updated 2020-08-12
Summary
Dogs are some of nature's greatest detectives, owing to their incredible sense of smell and ability to be trained. Most of us will be familiar with seeing trained sniffer dogs at airports looking for drugs and other prohibited items, but their skills don't stop there. The use of medical detection dogs is becoming increasingly common, as they are able to identify cancers, changes in blood sugar levels and even predict seizures. These are just a few examples of dogs playing a key role in public health. Many diseases can alter the way humans smell. A study undertaken by the London School of Hygiene \& Tropical Medicine (LSHTM) and Durham University has shown that dogs are able to accurately diagnose malaria. The investigators know that respiratory illnesses can alter your body odours, and thus the investigators plan to determine whether dogs are able to identify the novel coronavirus known as COVID-19 (or SARS-CoV-2).
COVID-19 can present itself asymptomatically (i.e. causing no apparent symptoms), which could lead to the spread of infection in the population. The investigators believe that dogs may be able to identify asymptomatic patients, as well as those who have mild symptoms (symptoms not requiring treatment, hospital stay or limiting normal activities). It is thought that a single medical detection dog stationed within an airport would be able to screen up to 750 people for COVID-19 infection in just 1 hour, informing those who are infected to isolate, preventing further spread of the disease.
In order to determine whether it is possible for dogs to accurately diagnose COVID-19, the investigators must first collect samples. NHS staff and members of their households that are eligible for SARS-CoV-2 screening, have been selected to participate in this study due to their potential exposure to this disease agent. In addition, participants from the general population who are displaying mild COVID-19 symptoms or have been exposed to COVID-19 will be recruited via hospitals, testing centers, outbreak testing programs and home testing programs. Initially, participants will attend their screening test as planned or confirm that they have had a swab test within the previous 24 hours. Immediately following this, the investigators will ask participants to collect samples of breath odour and body odour, which will be collected passively through the wearing of face masks, shirts, and nylon socks. The investigators will ask to be provided with the results of the SARS-CoV-2 screening swab, which will allow for us to determine whether participants are positive or negative for SARS-CoV-2. These odour samples will be grouped by positive or negative test results, and transported to LSHTM where these will be processed in order to prevent contact with the virus, negating the risk for dogs and their handlers.
A pilot study will be undertaken to confirm whether dogs are able to distinguish between positive and negative samples using traditional sniffer dog training methods. If this is possible, the investigators will proceed to the main study to determine the accuracy (known as sensitivity and specificity) of the dogs' ability to identify the virus. Both the handler and the dogs themselves will be 'blinded' to the samples, and thus unaware of which sample is which. When the data generated by these tests is entered, it will be confirmed whether or not the samples have been correctly identified.
The dogs will be trained to detect and report the detection of the volatile odours characteristic of COVID-19 infection. For quality control purposes the investigators also aim to characterise the COVID-19 odour profile by analysing samples with a special process called GC (gas chromatography) and/or GC-MS (gas chromatography coupled mass spectrometry). This will help to inform the identification of compounds showing differences between infected and non-infected samples.
The investigators believe that this work could be useful in the fight against COVID-19.
Conditions
- Covid19
Interventions
- BEHAVIORAL
-
Collection of odour samples
Samples of breath odours will be passively collected while participants wear the mask while breathing naturally, for at least 3 h. Skin odours will be passively collected by participants wearing the shirt and nylon socks for at least 12 h.
Sponsors & Collaborators
-
Durham University
collaborator OTHER -
Cardiff University
collaborator OTHER -
Medical Detection Dogs
collaborator UNKNOWN -
ARCTEC
lead INDUSTRY
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-07-02
- Primary Completion
- 2020-09-30
- Completion
- 2020-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Feel4Diabetes-study
NCT02393872 ·Status: UNKNOWN ·Phase: NA
-
Meta-Analyses of Low-risk Lifestyle Behaviours and Patient Important Outcomes
NCT03234101 ·Status: UNKNOWN
-
DeStress for Health: Partnering With Granville and Vance Counties to Reduce Stress and Cancer Risk
NCT03776890 ·Status: COMPLETED ·Phase: NA
-
Coronary Heart Disease Risk in Type 2 Diabetes
NCT01891786 ·Status: COMPLETED ·Phase: NA
-
Water Up@ At Home: An Intervention to Replace Sugary Drinks With Water
NCT05159622 ·Status: COMPLETED ·Phase: NA
-
Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
NCT01927783 ·Status: RECRUITING
-
NC Enhanced WISEWOMAN Project
NCT00288327 ·Status: COMPLETED ·Phase: NA
-
Self-screening of Cardiovascular Risk
NCT02373319 ·Status: COMPLETED ·Phase: NA
-
HELP Prevent Cancer Pilot Study
NCT02960542 ·Status: COMPLETED ·Phase: NA
-
Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology
NCT03167996 ·Status: COMPLETED ·Phase: NA
-
A Community-based Weight Loss Programme for Chinese Overweight Adults With Pre-diabetes
NCT03609697 ·Status: UNKNOWN ·Phase: NA
-
DeStress for Health: Partnering With Granville and Vance Counties to Reduce Stress and Cancer Risk (Part 2)
NCT05469334 ·Status: COMPLETED ·Phase: NA
-
Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved Communities
NCT05500274 ·Status: COMPLETED ·Phase: NA
-
A Nutrition Education Module to Modify Sugar Consumptions Among Individuals With Cardio Metabolic Risks
NCT05746000 ·Status: UNKNOWN ·Phase: NA
-
Lifestyle Intervention's Impact on Health Care Costs
NCT00717158 ·Status: COMPLETED ·Phase: NA
-
Health Dialogue Intervention Versus Opportunistic Screening for Type 2 Diabetes and Cardiovascular Disease Prevention
NCT06067178 ·Status: UNKNOWN ·Phase: NA
-
Using the Visualization for Lifestyle Change in Patients At Risk of Cardiovascular Diseases
NCT06226948 ·Status: COMPLETED ·Phase: NA
-
PocDoc Lipids Usability Study for Self-test Use
NCT06053788 ·Status: COMPLETED ·Phase: NA
-
The Role and Effectiveness of Diabetes Coaches in British Columbia
NCT02247271 ·Status: COMPLETED ·Phase: NA
-
"Screening for Change: Early Risk Detection and Integrated Prevention for Diabetes and Cardiovascular Diseases in the Marche Region"
NCT07344701 ·Status: RECRUITING
-
Preventing Diabetes in Latino Families
NCT05228522 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Med-South Lifestyle Study: Phase 1
NCT04421703 ·Status: COMPLETED ·Phase: NA
-
HomeStyles-Adults of Chinese Heritage
NCT06136793 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 Diabetes
NCT03037528 ·Status: COMPLETED ·Phase: NA
-
The Cork and Kerry Diabetes and Heart Disease Study (Phase II) Mitchelstown Cohort
NCT03191227 ·Status: COMPLETED